Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials
10.1002/cphy.c180013 37 HongC
These guidelines apply to the general adult population, and individuals taking Wegovy should consider adhering to the lower end of these recommendations , particularly during the initial titration phase when side effects are most pronounced
Exceptions exist for patients with documented allergies to specific inactive ingredients in brand-name products
*Wegovy is a registered trademark of Novo Nordisk